These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 17334747

  • 1. Antimicrobial therapy for Stenotrophomonas maltophilia infections.
    Nicodemo AC, Paez JI.
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):229-37. PubMed ID: 17334747
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.
    Al-Hamad A, Burnie J, Upton M.
    Can J Microbiol; 2011 Oct; 57(10):820-8. PubMed ID: 21942332
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial Resistance in Stenotrophomonas spp.
    Wang Y, He T, Shen Z, Wu C.
    Microbiol Spectr; 2018 Jan; 6(1):. PubMed ID: 29350131
    [Abstract] [Full Text] [Related]

  • 4. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
    Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J.
    Clin Infect Dis; 2001 May 15; 32 Suppl 2():S104-13. PubMed ID: 11320451
    [Abstract] [Full Text] [Related]

  • 5. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Wei C, Ni W, Cai X, Cui J.
    Infect Dis (Lond); 2015 May 15; 47(12):846-51. PubMed ID: 26167850
    [Abstract] [Full Text] [Related]

  • 6. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
    Nys C, Cherabuddi K, Venugopalan V, Klinker KP.
    Antimicrob Agents Chemother; 2019 Nov 15; 63(11):. PubMed ID: 31427300
    [Abstract] [Full Text] [Related]

  • 7. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.
    Al-Jasser AM.
    Ann Clin Microbiol Antimicrob; 2006 Sep 18; 5():23. PubMed ID: 16978420
    [Abstract] [Full Text] [Related]

  • 8. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA, Pezina-Cantú C, Garza-González E, Bocanegra-Ibarias P, Mendoza-Olazarán S, Morfín-Otero R, Camacho-Ortiz A, Villarreal-Treviño L, Rodríguez-Noriega E, Paláu-Davila L, Maldonado-Garza HJ, Flores-Treviño S.
    J Med Microbiol; 2017 Aug 18; 66(8):1102-1109. PubMed ID: 28771141
    [Abstract] [Full Text] [Related]

  • 9. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
    Juhász E, Krizsán G, Lengyel G, Grósz G, Pongrácz J, Kristóf K.
    Ann Clin Microbiol Antimicrob; 2014 Dec 31; 13():333. PubMed ID: 25551459
    [Abstract] [Full Text] [Related]

  • 10. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY, Lee K, Chung HS, Hong SG, Suh Y, Chong Y.
    Microb Drug Resist; 2017 Mar 31; 23(2):163-168. PubMed ID: 27294684
    [Abstract] [Full Text] [Related]

  • 11. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M, Tan X, Wu T, Jurkovic M, Vialichka A, Meyer K, Mendes RE, Wenzler E.
    J Clin Microbiol; 2020 Jan 28; 58(2):. PubMed ID: 31748318
    [Abstract] [Full Text] [Related]

  • 12. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
    Wu H, Wang JT, Shiau YR, Wang HY, Lauderdale TL, Chang SC, TSAR Hospitals.
    J Microbiol Immunol Infect; 2012 Apr 28; 45(2):120-6. PubMed ID: 22154599
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge.
    Gil-Gil T, Martínez JL, Blanco P.
    Expert Rev Anti Infect Ther; 2020 Apr 28; 18(4):335-347. PubMed ID: 32052662
    [Abstract] [Full Text] [Related]

  • 14. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia.
    Giamarellos-Bourboulis EJ, Karnesis L, Giamarellou H.
    Diagn Microbiol Infect Dis; 2002 Nov 28; 44(3):259-63. PubMed ID: 12493173
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C, Ni W, Cai X, Zhao J, Cui J.
    PLoS One; 2016 Nov 28; 11(3):e0152132. PubMed ID: 26999818
    [Abstract] [Full Text] [Related]

  • 16. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
    Tao CM, Li XC, Lü XJ, Li P, Yu RJ, Gao YY, Chen HL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan 28; 35(1):91-3. PubMed ID: 14981826
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.
    Church D, Lloyd T, Peirano G, Pitout J.
    Scand J Infect Dis; 2013 Apr 28; 45(4):265-70. PubMed ID: 23113657
    [Abstract] [Full Text] [Related]

  • 18. Review on Stenotrophomonas maltophilia: An Emerging Multidrug- resistant Opportunistic Pathogen.
    Majumdar R, Karthikeyan H, Senthilnathan V, Sugumar S.
    Recent Pat Biotechnol; 2022 Apr 28; 16(4):329-354. PubMed ID: 35549857
    [Abstract] [Full Text] [Related]

  • 19. Detection of multidrug resistant environmental isolates of acinetobacter and Stenotrophomonas maltophilia: a possible threat for community acquired infections?
    Govender R, Amoah ID, Kumari S, Bux F, Stenström TA.
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021 Apr 28; 56(2):213-225. PubMed ID: 33378222
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
    Juhász E, Pongrácz J, Iván M, Kristóf K.
    Acta Microbiol Immunol Hung; 2015 Sep 28; 62(3):295-305. PubMed ID: 26551572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.